U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896759) titled 'Serum S1P Levels and Dental Implant Osseointegration in Patients' on Oct. 20.
Brief Summary: This retrospective study aims to investigate whether a specific substance in the blood, called Sphingosine-1-Phosphate (S1P), is related to the degree of osseointegration around dental implants. We will review the medical records of 20 patients who have already completed their dental implant surgery and standard follow-up. The S1P levels will be measured using leftover blood samples from their routine preoperative examinations. By analyzing their existing dental x-ray images (CBCT) taken before surgery and during their routine 3-month follow...